These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16244572)

  • 1. [Speech therapy for the dysarthria of Parkinson's disease].
    Ozsancak C; Auzou P
    Rev Neurol (Paris); 2005 Sep; 161(8-9):857-61. PubMed ID: 16244572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease.
    Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE
    Cochrane Database Syst Rev; 2001; (2):CD002814. PubMed ID: 11406045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatments for dysarthria in Parkinson's disease.
    Pinto S; Ozsancak C; Tripoliti E; Thobois S; Limousin-Dowsey P; Auzou P
    Lancet Neurol; 2004 Sep; 3(9):547-56. PubMed ID: 15324723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Speech therapy in Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S163-6. PubMed ID: 12211157
    [No Abstract]   [Full Text] [Related]  

  • 5. Speech and language therapy for dysarthria in Parkinson's disease.
    Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE
    Cochrane Database Syst Rev; 2001; (2):CD002812. PubMed ID: 11406044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporating the Principles of Self-Management into Treatment of Dysarthria Associated with Parkinson's Disease.
    Yorkston K; Baylor C; Britton D
    Semin Speech Lang; 2017 Jul; 38(3):210-219. PubMed ID: 28618444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Speech therapy of dysarthria in Parkinson's disease].
    Cabrejo L; Auzou P; Ozsancak C; Hannequin D
    Presse Med; 2003 Nov; 32(37 Pt 1):1745-51. PubMed ID: 14663391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Speech therapy in Parkinson's disease: a study of the efficacy ad long term effects of intensive treatment.
    Robertson SJ; Thomson F
    Br J Disord Commun; 1984 Dec; 19(3):213-24. PubMed ID: 6508992
    [No Abstract]   [Full Text] [Related]  

  • 9. The Effects of Intensive Speech Treatment on Conversational Intelligibility in Spanish Speakers With Parkinson's Disease.
    Moya-Galé G; Goudarzi A; Bayés À; McAuliffe M; Bulté B; Levy ES
    Am J Speech Lang Pathol; 2018 Feb; 27(1):154-165. PubMed ID: 29351354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of speech and language therapy for a case of dysarthria associated with Parkinson's disease.
    Le Dorze G; Dionne L; Ryalls J; Julien M; Ouellet L
    Eur J Disord Commun; 1992; 27(4):313-24. PubMed ID: 1308695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The progress in the rehabilitation of dysarthria in Parkinson disease using LSVT (Lee Silverman Voice Treatment)].
    Kamińska I; Zebryk-Stopa A; Pruszewicz A; Dziubalska-Kołaczyk K; Połczyńska-Fiszer M; Pietrala D; Przedpelska-Ober E
    Otolaryngol Pol; 2007; 61(5):713-8. PubMed ID: 18552005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intrinsic and co-intrinsic vowel characteristics in cerebellar and parkinsonian dysarthrias].
    Baudelle E; Vaissière J; Renard JL; Roubeau B; Chevrie-Müller C
    Folia Phoniatr Logop; 2003; 55(3):137-46. PubMed ID: 12771465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of speech and language therapy techniques for speech problems in Parkinson's disease.
    Herd CP; Tomlinson CL; Deane KH; Brady MC; Smith CH; Sackley CM; Clarke CE
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002814. PubMed ID: 22895931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dysarthria across Parkinson's disease progression. Natural history of its components: dysphonia, dysprosody and dysarthria].
    Pinto S; Ghio A; Teston B; Viallet F
    Rev Neurol (Paris); 2010 Oct; 166(10):800-10. PubMed ID: 20800250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speech Versus Speaking: The Experiences of People With Parkinson's Disease and Implications for Intervention.
    Yorkston K; Baylor C; Britton D
    Am J Speech Lang Pathol; 2017 Jun; 26(2S):561-568. PubMed ID: 28654939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease.
    Baumann A; Nebel A; Granert O; Giehl K; Wolff S; Schmidt W; Baasch C; Schmidt G; Witt K; Deuschl G; Hartwigsen G; Zeuner KE; van Eimeren T
    Neurorehabil Neural Repair; 2018 Dec; 32(12):1055-1066. PubMed ID: 30444176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting Dysarthria Treatment Across Languages: The Hybrid Approach.
    Levy ES; Moya-Galé G
    J Speech Lang Hear Res; 2024 Sep; 67(9):2893-2902. PubMed ID: 38056466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Parkinsonian dysarthria].
    Gentil M; Pollak P; Perret J
    Rev Neurol (Paris); 1995 Feb; 151(2):105-12. PubMed ID: 7676137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease.
    Herd CP; Tomlinson CL; Deane KH; Brady MC; Smith CH; Sackley CM; Clarke CE
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002812. PubMed ID: 22895930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.